| MR编号 | PT/H/2388/003 |
|---|
| 药品名称 | Salmeterol/Fluticasone Genetic 25 microgram/250 microgram pressurized inhalation, suspension |
|---|
| 活性成分 | - fluticasone propionate 250.0 µg
- salmeterol xinafoate 25.0 µg
|
|---|
| 剂型 | Pressurised inhalation, suspension |
|---|
| 上市许可持有人 | GENETIC SPA
VIA G DELLA MONICA 26
CASTEL SAN GIORGIO SA
I-84083
ITALY |
|---|
| 参考成员国 - 产品名称 | Portugal (PT) |
|---|
| 互认成员国 - 产品名称 | - United Kingdom (Northern Ireland) (XI)
Salmeterol/Fluticasone Genetic 25 microgram/250 microgram pressurized inhalation, suspension - Germany (DE)
Salmeterol/Fluticasone Genetic 25 microgram/250 microgram per metered dose pressurized inhalation, suspension - France (FR)
- Italy (IT)
- Greece (GR)
- Bulgaria (BG)
Salmeterol/fluticasone Genetic - Czechia (CZ)
Salmeterol/Fluticasone Genetic 25 microgram / 250 microgram per metered dose pressurized inhalation, suspension. - Romania (RO)
- Slovakia (SK)
- Slovenia (SI)
|
|---|
| 许可日期 | 2019/02/20 |
|---|
| 最近更新日期 | 2024/03/04 |
|---|
| 药物ATC编码 | |
|---|